X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Priscilla VanderVeer

Priscilla VanderVeer Priscilla VanderVeer is a deputy vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Silver Spring, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Recent Posts

Researchers bring focus on science and medicine to California’s capital city

By Priscilla VanderVeer  |    May 29, 2018
Health care issues are often so highly politicized that it’s easy to lose sight of the people behind the scenes, especially the millions of medical professionals that wake up each morning with a...   Read More

SB 17 doesn’t address pressing prescription drug transparency issues for CA voters

By Priscilla VanderVeer  |    August 30, 2017
California’s SB 17 is one of a number of bills relating to prescription drug transparency around prescription medicine costs that are winding their way through U.S. statehouses.   Read More

17 years (and more) of medical discoveries

By Priscilla VanderVeer  |    March 24, 2017
Someone asked me recently if donated kidneys last forever. It’s been 17 years and a few days since I received one, which has lasted 17 years longer than I thought it would. That may not be...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    May 27, 2016
Threats to multiple myeloma progress – Progress in the fight against multiple myeloma has led to remarkable results, allowing 80 percent of newly diagnosed patients to live more than four years....   Read More

Nearly 4.5 million jobs and counting

By Priscilla VanderVeer  |    May 17, 2016
At PhRMA, we have the honor of highlighting the hope that America’s biopharmaceutical companies bring to patients in the form of innovative treatments and cures. But beyond the value that...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    May 6, 2016
Stopping opioid abuse – PhRMA and its members stand with patients, providers, law enforcement, policymakers and others in calling for and supporting national policies and action to address opioid...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 29, 2016
Fact Check Friday – When it comes to communications between with payers, biopharmaceutical companies are often constrained in sharing safety and efficacy information about medicines in...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 15, 2016
Competition works for pricing – Despite misleading claims to the contrary, a new report from IMS Institute for Healthcare Informatics found that net prices for brand medicines increased just 2.8...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    April 8, 2016
11 years of PPA – This week, we celebrated the 11th anniversary of the Partnership for Prescription Assistance (PPA) by launching a mobile app.  The new app will offer a single point of access to...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 1, 2016
Discriminatory effect of insurance plan structure – New research from Harvard’s Center for Health Law and Policy Innovation (CHLPI) shows evidence that some insurance plans are designed to...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Most Popular Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004